tegafur has been researched along with Common Bile Duct Neoplasms in 14 studies
Common Bile Duct Neoplasms: Tumor or cancer of the COMMON BILE DUCT including the AMPULLA OF VATER and the SPHINCTER OF ODDI.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this study was to clarify the safety and efficacy of combination chemotherapy of uracil-tegafur (UFT) and doxorubicin (UFD regimen), and to identify the prognostic factors in patients with unresectable advanced biliary tract cancer who received systemic chemotherapy." | 9.14 | A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer. ( Boku, N; Funakoshi, A; Furuse, J; Nagase, M; Ohkawa, S; Okusaka, T; Sato, T; Yamaguchi, T; Yamao, K, 2009) |
| "The purpose of this study was to clarify the safety and efficacy of combination chemotherapy of uracil-tegafur (UFT) and doxorubicin (UFD regimen), and to identify the prognostic factors in patients with unresectable advanced biliary tract cancer who received systemic chemotherapy." | 5.14 | A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer. ( Boku, N; Funakoshi, A; Furuse, J; Nagase, M; Ohkawa, S; Okusaka, T; Sato, T; Yamaguchi, T; Yamao, K, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Hosoda, K | 1 |
| Fukushima, K | 1 |
| Shimizu, A | 1 |
| Motoyama, H | 1 |
| Kubota, K | 1 |
| Notake, T | 1 |
| Sugenoya, S | 1 |
| Hayashi, H | 1 |
| Yasukawa, K | 1 |
| Kobayashi, R | 1 |
| Soejima, Y | 1 |
| Shoji, H | 1 |
| Morizane, C | 1 |
| Hiraoka, N | 1 |
| Kondo, S | 1 |
| Ueno, H | 1 |
| Ohno, I | 1 |
| Shimizu, S | 1 |
| Mitsunaga, S | 1 |
| Ikeda, M | 1 |
| Okusaka, T | 2 |
| Kim, K | 1 |
| Chie, EK | 1 |
| Jang, JY | 1 |
| Kim, SW | 1 |
| Han, SW | 1 |
| Oh, DY | 1 |
| Im, SA | 1 |
| Kim, TY | 1 |
| Bang, YJ | 1 |
| Ha, SW | 1 |
| Fujimoto, T | 1 |
| Ohtsuka, T | 1 |
| Date, K | 1 |
| Kimura, H | 1 |
| Matsunaga, T | 1 |
| Mori, Y | 1 |
| Miyasaka, Y | 1 |
| Mochidome, N | 1 |
| Oda, Y | 1 |
| Nakamura, M | 1 |
| Furuse, J | 1 |
| Ohkawa, S | 1 |
| Nagase, M | 1 |
| Funakoshi, A | 1 |
| Boku, N | 1 |
| Yamao, K | 2 |
| Yamaguchi, T | 1 |
| Sato, T | 2 |
| Abe, N | 1 |
| Sugiyama, M | 1 |
| Mizuno, H | 1 |
| Suzuki, Y | 1 |
| Masaki, T | 1 |
| Mori, T | 1 |
| Atomi, Y | 1 |
| Sakabe, R | 1 |
| Murakami, Y | 1 |
| Uemura, K | 1 |
| Sudo, T | 1 |
| Hashimoto, Y | 1 |
| Kondo, N | 1 |
| Nakashima, A | 1 |
| Ohge, H | 1 |
| Sueda, T | 1 |
| Hiyama, E | 1 |
| Hashida, H | 1 |
| Inoue, Y | 1 |
| Hattori, K | 1 |
| Kadono, K | 1 |
| Yoshimura, M | 1 |
| Yoshida, M | 1 |
| Abe, S | 1 |
| Miyake, M | 1 |
| Yoshitomi, M | 1 |
| Nomura, A | 1 |
| Ueda, S | 1 |
| Terajima, H | 1 |
| Osaki, N | 1 |
| Kitami, CE | 1 |
| Kurosaki, I | 1 |
| Koyama, Y | 1 |
| Makino, H | 1 |
| Hatakeyama, K | 1 |
| Sawaki, A | 1 |
| Mizuno, N | 1 |
| Hoki, N | 1 |
| Ishikawa, H | 1 |
| Takagi, T | 1 |
| Ishikawa, T | 1 |
| Ishikawa, N | 2 |
| Oota, H | 1 |
| Yoshida, T | 1 |
| Honma, A | 1 |
| Kamimura, T | 1 |
| Takeda, K | 1 |
| Ozaki, T | 1 |
| Iguchi, C | 1 |
| Nio, Y | 1 |
| Sato, Y | 1 |
| Watanabe, H | 1 |
| Ohishi, T | 1 |
| Abe, M | 1 |
| Yano, S | 1 |
| Sumi, S | 1 |
| Tamura, K | 1 |
| Moreira, LF | 1 |
| Iwagaki, H | 1 |
| Hizuta, A | 1 |
| Sakagami, K | 1 |
| Mimura, H | 1 |
| Orita, K | 1 |
| Shibata, T | 1 |
| Kondo, H | 1 |
| Ootani, I | 1 |
| Suzuki, H | 1 |
| Kawada, S | 1 |
1 trial available for tegafur and Common Bile Duct Neoplasms
| Article | Year |
|---|---|
A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
Topics: Aged; Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Du | 2009 |
13 other studies available for tegafur and Common Bile Duct Neoplasms
| Article | Year |
|---|---|
Survival Outcomes of Gemcitabine Plus S-1 Adjuvant Chemotherapy after Surgical Resection for Advanced Biliary Tract Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherap | 2021 |
Twenty-six cases of advanced ampullary adenocarcinoma treated with systemic chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Cispl | 2014 |
Prognostic Significance of Nodal Ratio in Patients Undergoing Adjuvant Chemoradiotherapy After Curative Resection for Ampullary Cancer.
Topics: Adult; Aged; Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy, Ad | 2016 |
Expression of Bcl-2 19-kDa interacting protein 3 predicts prognosis after ampullary carcinoma resection.
Topics: Adult; Aged; Aged, 80 and over; Ampulla of Vater; Biliary Tract Surgical Procedures; Biomarkers, Tum | 2016 |
Advanced ampullary carcinoma showing complete response to S-1: report of a case.
Topics: Ampulla of Vater; Antimetabolites, Antineoplastic; Cholecystectomy; Choledochostomy; Common Bile Duc | 2010 |
Prognostic significance of telomerase activity and human telomerase reverse transcriptase expression in ampullary carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Ampulla of Vater; Antineoplastic Agents; Biomarkers, Tumor; Carcinom | 2012 |
[A case of lung metastases of carcinoma of the ampulla of vater effectively treated with S-1].
Topics: Aged; Ampulla of Vater; Antimetabolites, Antineoplastic; Common Bile Duct Neoplasms; Drug Combinatio | 2012 |
Long-term survival after hepatectomy for hepatic recurrence of carcinoma of the papilla of Vater.
Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Aged; Ampulla of Vater; Antineoplastic Combined | 2005 |
[Effect of S-1 in a patient with post-operative recurrence of carcinoma of the ampulla of Vater].
Topics: Ampulla of Vater; Antimetabolites, Antineoplastic; Common Bile Duct Neoplasms; Drug Combinations; Fe | 2007 |
[A case of common bile duct cancer responding to MMC leucovorin, 5-FU, and UFT combination chemotherapy and radiation].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Common Bile Duct Ne | 1996 |
[A case of recurrent ampullary carcinoma of the papilla of Vater, in which a complete response was induced by combination therapy using radiotherapy and oral chemotherapy employing UFT and cyclophosphamide].
Topics: Administration, Oral; Adult; Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Combi | 1999 |
Can cytokines prolong survival in ampullary neuroendocrine carcinomas?
Topics: Ampulla of Vater; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Combined Modality Thera | 1992 |
[Two cases of obstructive jaundice due to extrahepatic carcinoma of the bile duct with marked response to daily oral administration of etoposide].
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chole | 1990 |